Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer. - Wikidata - awgldk - TriplyDB

Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer.

Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer.

http://www.wikidata.org/entity/Q39137546

about

Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype LGR5 is required for the maintenance of spheroid-derived colon cancer stem cells.Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases.Prognostic value of LGR5 in colorectal cancer: a meta-analysis.Distinct human stem cell populations in small and large intestine.Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis.LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.Genetic markers of recurrence in colorectal cancer.Cancer stem cells in human digestive tract malignancies.LGR5 promotes the proliferation of colorectal cancer cells via the Wnt/β-catenin signaling pathway.Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness.Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment.A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer.Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids.The Effect of miR-200c Inhibition on Chemosensitivity (5- FluoroUracil) in Colorectal Cancer.CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression.LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance.TROY is a promising prognostic biomarker in patients with colorectal cancer.Cancer stem cells in progression of colorectal cancer

P2860

Q26822406-93230BA5-E1BA-4936-9A77-B5DF91E203AE Q30353497-F34EF150-F488-4D73-89AC-DDC4373AB0C4 Q33811425-DBB9424B-262C-49E6-A10B-A8CEC0BDE865 Q35130563-6C6C8C8B-1795-4FD6-BABA-648B9096F031 Q35239978-3DD98344-C305-49D4-9BCD-4E8F892E928E Q35573649-D5198E07-CBD5-4D3F-AEE9-EFD8FFCA2583 Q35870637-FE00D3E7-CA31-46B3-9D0D-B1EADBB60E15 Q36605121-28FC25F3-7639-4CD4-B828-560E7EFA01BB Q38565301-2E54E453-4C51-4A13-9DD8-8A99DCF75630 Q38601789-184D6BED-08B0-4B9D-AFB4-72B413527E5F Q38857274-5815A663-91D3-49A5-88BF-D2EDF5166DAC Q39099572-13EEE2BF-E134-4A73-9E95-B8C77EB09B98 Q41321931-05AEB2FA-2E2F-4051-A8A0-21ECAF18519B Q47098203-BC700410-A8CE-4C4D-A7A9-327E5A55BD49 Q47771135-62A6E234-784F-4DE8-B759-E05351062BA4 Q49237718-C9456DDA-EFA1-4B0B-9685-90D61AC8B594 Q51057342-6A60340C-C40A-44E1-BCAA-C2934BA04842 Q51066392-D74A1800-C588-4083-A20E-65D20411727C Q51630354-9CE6DB87-D32C-45A2-98DB-D67A474A4928 Q51736765-7DDAEB8C-016B-44B0-8B6D-C0076CCB79DC Q52725560-8DDBD85F-7F16-4899-A23C-AC62E8B15A04 Q57150975-C786E4AA-902A-4AB9-9DBF-A98E3AEB1675

P2860

Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer.

http://www.wikidata.org/entity/Q39137546

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Overexpression of Lgr5 correla ...... otherapy in colorectal cancer.

@en

Overexpression of Lgr5 correla ...... otherapy in colorectal cancer.

@nl

type

label

Overexpression of Lgr5 correla ...... otherapy in colorectal cancer.

@en

Overexpression of Lgr5 correla ...... otherapy in colorectal cancer.

@nl

prefLabel

Overexpression of Lgr5 correla ...... otherapy in colorectal cancer.

@en

Overexpression of Lgr5 correla ...... otherapy in colorectal cancer.

@nl

P1433

Q39137546-1B8AB505-D6D0-4FDA-987B-1E2BABA9F3C0

P1476

Q39137546-1ACD0DD3-0C45-405C-94A6-9554AD272541

P2093

Q39137546-1DFE3A89-DCEA-4BA1-8755-21E0AFBDF6A9

Q39137546-267507DE-A687-44B4-BD1B-E31962710EFE

Q39137546-2C50DC3B-93DE-4F1F-99A9-1D7D04F16B04

Q39137546-3CCEFCF7-698C-4F27-AA23-441B5944AD8E

Q39137546-3FB10CB2-AD80-4807-8D24-2869A49F455B

Q39137546-527F0C5B-59AA-4F01-A20A-7877BCAC2DA8

Q39137546-57847E53-D39F-4960-B953-DBB59485AA12

Q39137546-8F7ECCB6-9BA2-4A18-AB1C-F83D4DF4ADF3

Q39137546-D2F6BA9B-2E33-404F-987C-1436B48B08A6

Q39137546-D6C21393-29C5-4F1A-8A44-DA8782FBDCD3

P2860

Q39137546-05674526-D60D-4992-9B2D-E2F5F4338CAC

Q39137546-07A09BAD-6136-49BC-A75B-BF4CB32EF3C6

Q39137546-0DE2F019-DE6E-4769-A007-A996681B973F

Q39137546-0EB388DE-E2E4-4B44-A817-7BAD2B8D4FD4

Q39137546-1788788E-6ED2-4AAA-91C7-DC37C8FC7B12

Q39137546-1CFC105A-B12D-43BE-9D38-D09D0F978582

Q39137546-203BD120-95F2-40A8-B746-7B3A69421EDA

Q39137546-21067F94-5681-448D-ADB5-367DC9793B0A

Q39137546-211E2B88-9191-4A85-AE9F-F46F4A3939F7

Q39137546-2230C29E-7B96-487D-8D43-02FE37308059

P2888

Q39137546-C90EEC0F-7BE9-4259-A295-42C9D6AA0F02

P304

Q39137546-B0C6E4AC-50EA-41AC-B384-0D7C555E09EB

P31

Q39137546-264B3FDC-54D7-4100-949B-7EE24EA69DFC

P356

Q39137546-0F77A4C4-A5C5-4C44-98D2-9A7A7A17042A

P433

Q39137546-DBDF493E-1A40-424F-80FC-D39D70F1CFE2

P478

Q39137546-76749E0B-B375-47DC-8094-22E73133FA94

P577

Q39137546-5D15AF63-1B1A-4345-9840-C904BEAC9804

P698

Q39137546-85113BC6-0056-4E1B-AC57-BF347ADA9BF9

P921

Q39137546-21461806-DA5F-47E6-9767-1F6BC36A1312

Q39137546-2E949946-7333-4717-AB29-6A14DE29DF24

Q39137546-F3B2B9F0-9DB9-4287-BCED-C27D3C4BE45B

P356

S00384-013-1721-X

P1433

International Journal of Colorectal Disease

P1476

Overexpression of Lgr5 correla ...... otherapy in colorectal cancer.

@en

P2093

Cheng-Lung Hsu

http://www.w3.org/2001/XMLSchema#string

Hua-Chien Chen

http://www.w3.org/2001/XMLSchema#string

Hung-Chih Hsu

http://www.w3.org/2001/XMLSchema#string

Jinn-Shiun Chen

http://www.w3.org/2001/XMLSchema#string

Kai-Chi Tseng

http://www.w3.org/2001/XMLSchema#string

Rei-Ping Tang

http://www.w3.org/2001/XMLSchema#string

Shu-Jen Chen

http://www.w3.org/2001/XMLSchema#string

Tsai-Sheng Yang

http://www.w3.org/2001/XMLSchema#string

Yi-Shiuan Liu

http://www.w3.org/2001/XMLSchema#string

Ying Liang

http://www.w3.org/2001/XMLSchema#string

P2860

LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines

Cancer statistics, 2012

Identification and expansion of human colon-cancer-initiating cells

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

Identification of stem cells in small intestine and colon by marker gene Lgr5

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Crypt stem cells as the cells-of-origin of intestinal cancer

Intra-tumour heterogeneity: a looking glass for cancer?

P2888

s00384-013-1721-x

P304

1535-1546

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00384-013-1721-X

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23784051

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer